-Reuters
Related Posts
Autolus Therapeutics’ Leukemia Trial Meets Primary Goal Of Remission Rate, Shares Fall After $150M Capital Raise
Autolus Therapeutics plc’s (NASDAQ:AUTL) Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic…
Can The Economy Weather Inflation, A Winter Storm, Elon Musk?
The S&P 500 traded lower for the third consecutive week on concerns inflation may be more stubborn than anticipated.
Enjoy Summer Solstice With The Hottest New Cannabis Products: Premium Flower Strains, Infused Gummies, And Pre-Rolls
Discover the latest cannabis products in this exclusive round-up from Benzinga.
We've curated a diverse selection of new launches by cannabis operators, catering to both connoisseurs and casual enthusiasts.